Matinas BioPharma Holdings, Inc. (MTNB) Total liabilities 2015–2024
Matinas BioPharma Holdings, Inc. (MTNB) total liabilities at each fiscal year-end, per SEC filings.
$5.9MFY2024 · since FY2015: $1.1M → $5.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $5.9M | -28.4% |
| FY2023 | $8.2M | -7.4% |
| FY2022 | $8.8M | +22.0% |
| FY2021 | $7.2M | +0.7% |
| FY2020 | $7.2M | +89.1% |
| FY2019 | $3.8M | +1.6% |
| FY2018 | $3.7M | +40.3% |
| FY2017 | $2.7M | +14.3% |
| FY2016 | $2.3M | +105.9% |
| FY2015 | $1.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice